Michael Blind

Papers

1

Total Citations

94

H-Index

1

About

Michael Blind is a pioneering figure in functional proteomics, best known for his foundational work on intramers—intracellularly expressed antibodies that serve as powerful tools for probing protein function in living cells. His seminal 2001 paper, "Intramers as promising new tools in functional proteomics," has garnered 94 citations and remains a cornerstone reference in the field, establishing a framework for using these engineered binding molecules to disrupt protein-protein interactions and study signaling pathways. Blind's research has significantly advanced the understanding of how to target and manipulate proteins within their native cellular environment, offering a versatile alternative to traditional genetic knockouts. His contributions have not only shaped the development of novel proteomic strategies but also opened new avenues for therapeutic target validation. With a career marked by innovative approaches to molecular biology, Blind's work continues to inspire researchers exploring the intersection of antibody engineering and cell biology, solidifying his reputation as a key innovator in the quest to decode the functional proteome.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
Intramers as promising new tools in functional proteomics
94 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 2

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago